SLN
Price
$6.45
Change
-$0.30 (-4.44%)
Updated
Nov 19, 01:57 PM (EDT)
Capitalization
226.72M
119 days until earnings call
Intraday BUY SELL Signals
STOK
Price
$28.52
Change
-$0.41 (-1.42%)
Updated
Nov 19, 04:16 PM (EDT)
Capitalization
1.65B
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SLN vs STOK

Header iconSLN vs STOK Comparison
Open Charts SLN vs STOKBanner chart's image
Silence Therapeutics
Price$6.45
Change-$0.30 (-4.44%)
Volume$200
Capitalization226.72M
Stoke Therapeutics
Price$28.52
Change-$0.41 (-1.42%)
Volume$1.05K
Capitalization1.65B
SLN vs STOK Comparison Chart in %
SLN
Daily Signal:
Gain/Loss:
STOK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SLN vs. STOK commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLN is a Hold and STOK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (SLN: $6.72 vs. STOK: $28.95)
Brand notoriety: SLN and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLN: 143% vs. STOK: 88%
Market capitalization -- SLN: $226.72M vs. STOK: $1.65B
SLN [@Biotechnology] is valued at $226.72M. STOK’s [@Biotechnology] market capitalization is $1.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLN’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • SLN’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLN’s TA Score shows that 6 TA indicator(s) are bullish while STOK’s TA Score has 6 bullish TA indicator(s).

  • SLN’s TA Score: 6 bullish, 3 bearish.
  • STOK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SLN is a better buy in the short-term than STOK.

Price Growth

SLN (@Biotechnology) experienced а 0.00% price change this week, while STOK (@Biotechnology) price change was +15.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

SLN is expected to report earnings on Mar 18, 2026.

STOK is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($1.65B) has a higher market cap than SLN($227M). STOK YTD gains are higher at: 162.466 vs. SLN (-2.326). STOK has higher annual earnings (EBITDA): 42.3M vs. SLN (-84.82M). STOK has more cash in the bank: 248M vs. SLN (114M). SLN has less debt than STOK: SLN (0) vs STOK (2.3M). STOK has higher revenues than SLN: STOK (200M) vs SLN (27.2M).
SLNSTOKSLN / STOK
Capitalization227M1.65B14%
EBITDA-84.82M42.3M-201%
Gain YTD-2.326162.466-1%
P/E RatioN/A39.68-
Revenue27.2M200M14%
Total Cash114M248M46%
Total Debt02.3M-
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLNSTOK
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SLN
Daily Signal:
Gain/Loss:
STOK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDEQX76.51N/A
N/A
Fidelity Disciplined Equity
AOFAX19.40N/A
N/A
Alger Small Cap Focus A
VICAX23.51N/A
N/A
USA Mutuals Vice A
JMGMX55.14-0.02
-0.04%
JPMorgan Mid Cap Growth R6
IRPSX10.33-0.03
-0.29%
VY® T. Rowe Price Equity Income S

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+0.30%
CLLS - SLN
43%
Loosely correlated
-0.72%
CMVLF - SLN
38%
Loosely correlated
N/A
ABCZF - SLN
36%
Loosely correlated
N/A
NGNE - SLN
34%
Loosely correlated
-5.39%
STOK - SLN
33%
Loosely correlated
+7.42%
More